Published in:
01-10-2012 | Case Report
Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever
Published in: Rheumatology International | Issue 10/2012
Login to get accessAbstract
Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by self-limited recurrent attacks of fever and serositis. The serious complication of FMF is AA-type amyloidosis, which can result in end-stage renal disease. Although colchicine is effective in the majority of patients, there is no established treatment for those who are resistant or intolerant to colchicine. We herein report the efficacy of anakinra in a 52-year-old Turkish patient with FMF, secondary amyloidosis and renal transplant, who was resistant to colchicine treatment.